4 completed, 1 unknown. 5 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 5 | Completed 4, Unknown 1 |
Follow Leukemia, Mast-Cell: new trials by email Literature Review of Leukemia, Mast-Cell trials Research Report on Leukemia, Mast-Cell
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Ketamine Hydrochloride and Best Pain Management in Treating Cancer Patients With Neuropathic Pain ketamine hydrochloride, pharmacogenomic studies, questionnaire administration - Cancer | Phase 3 | Unknown | University of Glasgow | 214 | 2009-04-01 | 2011-05-13 |
| American Ginseng in Treating Patients With Fatigue Caused by Cancer American ginseng, placebo - Chronic Myeloproliferative Disorders, Fatigue | Phase 3 | Completed | Alliance for Clinical Trials in Oncology | 364 | 2008-10-01 | 2017-02-09 |
| Personalized Information or Basic Information in Helping Patients Make Decisions About Participating in a Clinical Trial educational intervention - Brain and Central Nervous System Tumors, Chronic Myeloproliferative Disorders | Phase 3 | Completed | Case Comprehensive Cancer Center | 583 | 2008-04-01 | 2020-07-27 |
| Darbepoetin Alfa With or Without Iron in Treating Anemia Caused By Chemotherapy in Patients With Cancer darbepoetin alfa, ferrous sulfate, sodium ferric gluconate complex in sucrose - Anemia, Leukemia | Phase 3 | Completed | Mayo Clinic | 502 | 2006-01-01 | 2011-05-17 |
| Opioid Titration Order Sheet or Standard Care in Treating Patients With Cancer Pain educational intervention, Titrated pain management, questionnaire administration - Brain and Central Nervous System Tumors, Chronic Myeloproliferative Disorders | Phase 3 | Completed | Vanderbilt-Ingram Cancer Center | 98 | 2005-05-01 | 2012-09-06 |
Burkitt Lymphoma (5) · Hodgkin Disease (5) · Immunoblastic Lymphadenopathy (5) · Immunoglobulin Light-chain Amyloidosis (5) · Leukemia, Biphenotypic, Acute (5) · Leukemia, Hairy Cell (5) · Leukemia, Large Granular Lymphocytic (5) · Leukemia, Lymphocytic, Chronic, B-Cell (5) · Leukemia, Prolymphocytic (5) · Lymphoma, B-Cell, Marginal Zone (5) · Lymphoma, Extranodal NK-T-Cell (5) · Lymphoma, Follicular (5) · Lymphoma, Large B-Cell, Diffuse (5) · Lymphoma, Large-Cell, Anaplastic (5)
Amyloidosis (5) · Blood Protein Disorders (5) · Cardiovascular Diseases (5) · Chronic Disease (5) · DNA Virus Infections (5) · Disease Attributes (5) · Epstein-Barr Virus Infections (5) · Hematologic Diseases (5) · Hemic and Lymphatic Diseases (5) · Hemorrhagic Disorders (5) · Hemostatic Disorders (5) · Herpesviridae Infections (5) · Immune System Diseases (5) · Immunoproliferative Disorders (5) · Infections (5)
Early Intervention, Educational (2) · Asian ginseng (1) · Darbepoetin alfa (1) · Ketamine (1) · Pharmacogenomic Testing (1) · Sucrose (1) · ferric gluconate (1) · ferrous sulfate (1)
Alliance for Clinical Trials in Oncology (1) · Case Comprehensive Cancer Center (1) · Mayo Clinic (1) · University of Glasgow (1) · Vanderbilt-Ingram Cancer Center (1)
United States (4) · United Kingdom (1)
Barry J.A. Laird, MD (1) · Charles L. Loprinzi, MD (1) · Debra Barton, RN, PhD, AOCN, FAAN (1) · Marie T. Fallon (1) · Nancy Wells, DNSc, RN (1) · Neal J. Meropol, MD (1) · Tom R. Fitch, M.D. (1)
P30CA015083 (1), P30CA068485 (1), R01CA127655 (1)